Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.05 USD
Change Today +0.0015 / 3.27%
Volume 66.9K
CORX On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

cortex pharmaceuticals inc (CORX) Snapshot

Open
$0.05
Previous Close
$0.05
Day High
$0.05
Day Low
$0.04
52 Week High
10/7/14 - $0.09
52 Week Low
05/19/14 - $0.02
Market Cap
11.5M
Average Volume 10 Days
143.0K
EPS TTM
$-0.07
Shares Outstanding
240.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CORTEX PHARMACEUTICALS INC (CORX)

Related News

No related news articles were found.

cortex pharmaceuticals inc (CORX) Related Businessweek News

No Related Businessweek News Found

cortex pharmaceuticals inc (CORX) Details

Cortex Pharmaceuticals, Inc. engages in the discovery and development of pharmaceuticals for the treatment of respiratory disorders. The company is also involved in clinical development in the areas of neurological and psychiatric disorders. It develops ampakine compounds comprising CX1739 for the treatment of patients with central and mixed sleep apnea; and CX1942, a soluble ampakine, to be used in an injectable formulation as a rescue medication for the emergency treatment of drug-induced respiratory depression. The company was founded in 1987 and is headquartered in Glen Rock, New Jersey.

1 Employees
Last Reported Date: 03/30/15
Founded in 1987

cortex pharmaceuticals inc (CORX) Top Compensated Officers

Executive Chairman, Chief Executive Officer a...
Total Annual Compensation: --
Chief Financial Officer, Vice President and D...
Total Annual Compensation: --
Vice President, Treasurer, Secretary and Dire...
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

cortex pharmaceuticals inc (CORX) Key Developments

Cortex Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt

Cortex Pharmaceuticals, Inc. filed its 10-K on Mar 30, 2015 for the period ending Dec 31, 2014. In this report its auditor, Haskell & White LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Cortex Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt

Cortex Pharmaceuticals, Inc. filed its 10-K on Jan 06, 2015 for the period ending Dec 31, 2013. In this report its auditor, Haskell & White LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Cortex Pharmaceuticals, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-13-2015 04:30 PM

Cortex Pharmaceuticals, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-13-2015 04:30 PM. Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States. Speakers: Arnold S. Lippa, Executive Chairman, Chief Executive Officer and President.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CORX:US $0.05 USD +0.0015

CORX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amorfix Life Sciences Ltd C$0.05 CAD -0.005
Eli Lilly & Co $72.47 USD -1.02
Novartis AG SFr.97.20 CHF -1.85
Pfizer Inc $35.04 USD -0.15
View Industry Companies
 

Industry Analysis

CORX

Industry Average

Valuation CORX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 166.5x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 160.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CORTEX PHARMACEUTICALS INC, please visit www.cortexpharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.